[Monoclonal antibody metabolism during the growth of hybridoma cells]
- PMID: 2972097
[Monoclonal antibody metabolism during the growth of hybridoma cells]
Abstract
Metabolism of monoclonal antibodies (MAb) during the growth of mouse hybridoma, producing MAb to phage lambda, has been studied. It was shown that the specific production of MAb decreased by 25-35% in the stationary phase of growth in comparison with the middle of the exponential growth phase, which was associated with the decrease in the rate of MAb synthesis. The secretion kinetics of MAb did not change during the growth of hybridoma cells. MAb did not degrade inside the cells and in the culture medium after being secreted. The ratio of the synthesis rate of MAb to that of cellular proteins increased from 7-10% in the exponential growth phase to 14-18% in the stationary phase, which points to a specific regulation of MAb synthesis in comparison with cellular proteins. Possible regulation mechanisms for synthesis of MAb and cellular proteins during the growth of hybridoma cells are discussed.
Similar articles
-
[Protein metabolism during the growth of hybridoma cells].Tsitologiia. 1988 Apr;30(4):449-53. Tsitologiia. 1988. PMID: 2970703 Russian.
-
The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.Biotechnol Prog. 1999 Jul-Aug;15(4):655-66. doi: 10.1021/bp990068m. Biotechnol Prog. 1999. PMID: 10441357
-
A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.Biotechnol Prog. 2005 Jan-Feb;21(1):140-7. doi: 10.1021/bp049826l. Biotechnol Prog. 2005. PMID: 15903251
-
Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.Indian J Exp Biol. 1998 Feb;36(2):125-35. Indian J Exp Biol. 1998. PMID: 9754040 Review.
-
Getting higher yields of monoclonal antibody in culture.Indian J Physiol Pharmacol. 1998 Apr;42(2):155-71. Indian J Physiol Pharmacol. 1998. PMID: 10225044 Review.